Le Lézard
Classified in: Science and technology, Business
Subjects: TNM, JVN

Ekinops: Preliminary Discussions With Nokia Corporation Regarding a Possible Acquisition of Alcatel Submarine Networks


PARIS, October 18, 2018 /PRNewswire/ --

Following press reports on a potential financial transaction involving EKINOPS (Euronext Paris - FR0011466069 - EKI), a leading supplier of telecommunications solutions for telecom operators, the company confirms that it has initiated preliminary discussions with Nokia Corporation regarding a possible acquisition of Alcatel Submarine Networks.

There is no certainty at this stage that these discussions can lead to any agreement or any operation.

Ekinops will comply with its legal and regulatory communications obligations and will not make any further comments thereon unless these discussions result in an agreement or are discontinued.

This press release, from which no legal consequences may be drawn, is for information purposes only. It does not constitute or form part of any offer or solicitation to purchase or subscribe for or to sell securities of Ekinops.

About EKINOPS
Ekinops is a leading provider of open and fully interoperable Layer 1, 2 and 3 solutions to service providers around the world. Our programmable and highly scalable solutions enable the fast, flexible and cost-effective deployment of new services for both high-speed, high-capacity optical transport as well as virtualization-enabled managed enterprise services.

Our product portfolio consists of two highly complementary product sets. One, marketed under the Ekinops 360 brand name, provides a single, fully integrated platform for metro, regional, and long-haul applications. The other, marketed under the OneAccess brand name, provides a wide choice of physical and virtualized deployment options for Layer 2 and Layer 3 network functions.

As service providers embrace SDN and NFV deployment models, Ekinops' solutions enable them to deploy today in the knowledge that they can seamlessly migrate to an open virtualized delivery model at a time of their choosing.

A global organization, with operations in 4 continents; Ekinops (EKI) - a public company traded on the Euronext Paris exchange - is headquartered in Lannion, France, and Ekinops Corp., a wholly-owned subsidiary, is incorporated in the USA.

Name: Ekinops
ISIN code: FR0011466069
Ticker: EKI
Total number of shares: 21,529,161
For more information, visit http://www.ekinops.net

EKINOPS contact
Didier Brédy    
Chairman
[email protected]

Investors
Mathieu Omnes
Investor relation
Tél.: +33-(0)1-53-67-36-92
[email protected]

Press
Nicolas Bouchez
Press relation
Tél.: +33-(0)1-53-67-36-74
[email protected]

SOURCE Ekinops


These press releases may also interest you

at 05:30
BrightPoint (BP) LLC, an 8(a) joint venture between Buchanan & Edwards (BE) and i3, is pleased to announce its successful bid for a position on the U.S. Department of Commerce's Commerce Acquisition for Transformational Technology Services (CATTS)...

at 05:30
The "High Net Worth (Hnw) Asset Allocation Trends 2024" report has been added to  ResearchAndMarkets.com's offering. Drawing on our 2023 Global Wealth Managers Survey, this report analyzes HNW asset allocation strategies in 24 key markets. In...

at 05:30
FinVolution Group ("FinVolution," or the "Company") , a leading fintech platform, today announced that its Philippines financial application, Juanhand, has entered into a strategic cooperation agreement with SeaBank Philippines Bank ("SeaBank"), an...

at 05:20
Engel & Völkers Florida today announced the outstanding achievement of Michael Ledwitz, Broker/Owner of Engel & Völkers Boca Raton, who has been recognized as the Top Advisor in GCI for his outstanding performance in 2023. This prestigious accolade...

at 05:05
Building upon its recent success in revamping its indices product offering, leading CFD broker Vantage Markets ("Vantage") is thrilled to announce the introduction of enhanced website features and app enhancements, further solidifying its position as...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...



News published on and distributed by: